Specializing in the Early Detection of Breast Cancer
Bethesda Women’s Health Center provides comprehensive diagnostic services for both women and men with state-of-the-art technology and a caring, compassionate staff. Accredited by the American College of Radiology, our Center meets all professional standards of safety and quality and is designated by the FDA (Food and Drug Administration) as a Certified Mammography Facility.
Bethesda Women’s Health Center is one of the first women’s centers in Florida to offer 3D mammography (breast tomosynthesis) for breast cancer screening. Click here to learn more about this latest innovation in breast imaging technology and breast cancer detection.
Our full complement of services is designed to meet a woman’s needs through all stages of life. Whether she is concerned about her risk of breast cancer, or learning to manage menopause symptoms and osteoporosis, every stage is an important milestone for her life.
Bethesda Women's Health Center is located at Bethesda Health City, 10301 Hagen Ranch Road, Suite A-920, Boynton Beach, FL, 33437. To schedule an appointment, call 561.374.5700. For more information about our services, call 561.374.5300.
Bethesda Women’s Health Center introduces new program to identify patients at high risk for an inherited gene mutation
Bethesda Women’s Health Center, is proud to introduce a new program to identify our high-risk patients using a revised family history questionnaire and the criteria published in the National Comprehensive Cancer Network® (NCCN®). Now, at the time of your annual mammogram, our staff can help determine if you could benefit from genetic testing.
Carol A. Adami, M.D.
Board Certified Radiologist and
Medical Director of Bethesda
Women’s Health Center
Carol Adami, M.D., Board Certified Radiologist and Medical Director of Bethesda Women’s Health Center, speaks on how genetic testing for breast and ovarian cancer can benefit women.
Who needs genetic testing?
Most breast and ovarian cancers occur by chance. Only 5 to 10 percent are attributed to an inherited gene mutation of the BRCA1 or BRCA2, but a woman with the inherited gene mutation has up to an 87 percent risk for developing breast cancer and up to a 44 percent risk for developing ovarian cancer in her lifetime.
Anyone with the following personal or family history, may be a candidate for BRCA genetic testing:
Pre-menopausal breast cancer (breast cancer before age 50)
Breast and ovarian cancer in the same individual
Ovarian cancer at any age
Male breast cancer
Bilateral breast cancer
Known BRCA1 or 2 in either side of the family, mother or father
Ashkenazi Jewish ancestry
3 family members affected by either pancreatic, breast or ovarian cancer
How is gene testing done?
Patients determined to be at high risk for a gene mutation of BRCA 1 or 2 will be offered additional information. If they choose to continue with further analysis, our technologist will collect a saliva or blood sample that is tested at Myriad Genetics Laboratory. Results are usually available within four weeks. A physician referral is not necessary.
What is the cost? Is it covered by insurance?
Genetic testing can cost between $375 and $4,200 depending on the type of testing needed. Most insurance companies, including Medicare cover the cost when specific criteria are met. Myriad will verify your insurance coverage before running the test and let you know exactly how much it will cost. They will only run the test if the patient authorizes the expense, and will work out a payment plan when needed.
What can I do if I test positive?
Patients who undergo genetic testing will meet with our nurse practitioner to review their results, complete the risk assessment and arrange for follow up care.
You can also be proactive with your medical care and find ways to reduce your risk for cancer. Surgical and medical interventions can reduce the risk of breast and ovarian cancer by more than 90%. Supplemental screening tests, such as annual MRI and more frequent physical exams, can detect cancer at an earlier stage than routine screening.
What should people remember about genetic testing for breast and ovarian cancer?
Although only 1 in 400 women in the United States carry the BRCA mutation, the incidence in Ashkenazi Jewish women is 1 in 40. The gene can be inherited from either your mother or your father. If one of your parents is a carrier, you have a 50% chance of having the mutation and passing it on to your offspring.
It is always best to test the person in the family who has been affected with cancer but useful information can come from testing non-affected family members when appropriate. Our staff is here to help you decide what is best for you.